RSS

lapatinib

breast-cancer-cells-stained-for-dna-(red)-nfkb-(green)-and-a-reactive-oxygen-species-probe-(blue)-julia-sero-the-icr-2011.jpg

photo: Julia Sero/the ICR

A combination of lapatinib and trastuzumab (Herceptin) before surgery shrinks and may even destroy tumours in women with HER2 positive disease within 11 days, according to new research more

News